MERRIMACK PHARMACEUTICALS INC
MERRIMACK PHARMACEUTICALS INC (MACK) is a publicly traded company in the Unknown sector. Across all available filings, 36 corporate insiders have executed 538 transactions totaling $44.9M, demonstrating a bullish sentiment with $13.1M in net insider flow. The most recent transaction on Dec 28, 2023 involved a purchase of 857 shares valued at $11.4K.
MACK Insider Activity Summary
Who Is Buying MACK Stock?
No significant insider buying has been recorded for MACK in the recent period.
Who Is Selling MACK Stock?
No significant insider selling has been recorded for MACK in the recent period.
Is MERRIMACK PHARMACEUTICALS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MACK is bullish with an Insider Alignment Score of 65/100 and a net flow of $13.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MACK Frequently Asked Questions
Understanding MACK Insider Activity
Insider trading at MERRIMACK PHARMACEUTICALS INC (MACK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 36 insiders are actively trading MACK stock, having executed 538 transactions in the past 90 days. The most active insider is Robert J. Mulroy (Executive), who has made 34 transactions totaling $7.8M.
Related Tools
Track MERRIMACK PHARMACEUTICALS INC Insider Activity
Get notified when executives and directors at MACK file new Form 4 transactions